Literature DB >> 16622859

Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.

Roberta Marongiu1, Daniele Ghezzi, Tamara Ialongo, Francesco Soleti, Antonio Elia, Stefania Cavone, Alberto Albanese, Maria Concetta Altavista, Paolo Barone, Livia Brusa, Pietro Cortelli, Lucia Petrozzi, Cesa Scaglione, Paolo Stanzione, Michele Tinazzi, Massimo Zeviani, Bruno Dallapiccola, Anna Rita Bentivoglio, Enza Maria Valente, Barbara Garavaglia.   

Abstract

To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parkinson's disease (PD; 822 sporadic and 250 familial): 20 patients (1.9%) carried the G2019S mutation, 11 patients (1.3%) were sporadic, and 9 (4.3%) had a positive family history. Considering only probands with autosomal dominant inheritance, the G2019S frequency raises to 5.2%. All presented a typical phenotype with variable onset and shared the common ancestral haplotype. Mutation frequency raised from 1.2% in early onset PD to 4.0% in late onset PD. (c) 2006 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622859     DOI: 10.1002/mds.20890

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

Review 1.  The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Avner Thaler; Elissa Ash; Ziv Gan-Or; Avi Orr-Urtreger; Nir Giladi
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

2.  Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease.

Authors:  Alessandro Stefani; Francesco Marzetti; Mariangela Pierantozzi; Simona Petrucci; Enrica Olivola; Salvatore Galati; Mario Stampanoni Bassi; Paola Imbriani; Enza Maria Valente; Francesco Saverio Pastore
Journal:  Neurol Sci       Date:  2012-03-22       Impact factor: 3.307

3.  No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy.

Authors:  Andrea Tedde; Silvia Bagnoli; Elena Cellini; Benedetta Nacmias; Silvia Piacentini; Sandro Sorbi
Journal:  Cell Mol Neurobiol       Date:  2007-09-11       Impact factor: 5.046

Review 4.  Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Authors:  Elisa Greggio; Mark R Cookson
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.